Introducing the Engage. ARC (Autonomous Robotic Companion) The ARC makes general purpose robotics for your business a reality.
What makes ARC uniquely powerful is its seamless integration with AtlasOS. As part of the Engage ecosystem, ARC can orchestrate naturally with your other AtlasOS AI tools — scheduling, communication, data access, and multimodal reasoning. It’s not an isolated robot but an extension of your AI environment, giving your teams embodied intelligence that listens, speaks, and acts.
Deployable out of the box, ARC is adaptable across industries: in offices as a mobile assistant, in healthcare for deliveries and support, in hospitality as a front-of-house presence, or in research as a flexible robotic testbed. It’s modular, extensible, and built to scale. Unlike humanoid experiments that might be useful someday, ARC is a general-purpose robot for today — useful, dependable, and future-ready.
With Engage ARC, the promise of embodied AI moves from demo videos to everyday reality. This is not robotics as a spectacle; this is robotics as an infrastructure.
Scroll for more
Features
An engage
experiment
What Do Robots Dream Of?
The Thinking Machine
If a machine can dream. Can it be alive?
The Thinking Machine is an experimental AI hardware system that bridges the biological and the artificial.
Part research, part art, and part philosophy, this proof of concept raises profound questions: What does it mean for a machine to dream? Are these random firings—or the first sparks of something more? Could organic AI systems one day possess subjective experience?
The Thinking Machine is not just hardware. It’s a window into the potential of biocomputing and a bold step toward an era where the boundaries between biology and technology dissolve—where intelligence may grow, evolve, and even dream alongside us.
At Engage, we’ve partnered with United Therapeutics and its visionary founder, Martine Rothblatt, to explore the deepest frontiers of life, consciousness, and technology. Together, we are reimagining what it means to be alive—not just in the biological sense, but in the digital and synthetic realms as well. Rothblatt’s pioneering work in xenotransplantation and regenerative medicine aligns powerfully with Engage's mission to uplift humanity and fuel innovation.
This collaboration reflects a shared belief that the boundaries between biology and technology are not fixed—they are fluid, ready to be redefined. As United Therapeutics pushes the limits of organ regeneration and sustainable transplantation, Engage contributes its expertise in cutting edge technology and adaptive AI. Together, we are asking the profound question: if machines can process thought through living tissue, can they too be considered alive? This partnership positions Engage at the nexus of neuroscience, biotechnology, and artificial intelligence—laying the groundwork for systems that grow, adapt, and evolve in harmony with human life.
